Spirocyclic degronimers for target protein degradation
申请人:C4 Therapeutics, Inc.
公开号:US10660968B2
公开(公告)日:2020-05-26
This invention provides compounds that have spirocyclic E3 Ubiquitin Ligase targeting moieties (Degrons), which can be used as is or linked to a targeting ligand for a protein that has been selected for in vivo degradation, and methods of use and compositions thereof as well as methods for their preparation.
SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
申请人:C4 Therapeutics, Inc.
公开号:EP3454862A1
公开(公告)日:2019-03-20
[EN] SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION<br/>[FR] DÉGRONIMÈRES SPIROCYCLIQUES POUR LA DÉGRADATION DE PROTÉINES CIBLES
申请人:C4 THERAPEUTICS INC
公开号:WO2017197036A1
公开(公告)日:2017-11-16
This invention provides compounds that have spirocyclic E3 Ubiquitin Ligase targeting moieties (Degrons), which can be used as is or linked to a targeting ligand for a protein that has been selected for in vivo degradation, and methods of use and compositions thereof as well as methods for their preparation.
Stereoselective synthesis of substituted N-heterocycles via sequential cross metathesis—reductive cyclization
作者:Julian Gebauer、Purnama Dewi、Siegfried Blechert
DOI:10.1016/j.tetlet.2004.11.030
日期:2005.1
A diastereoselective synthesis of substituted mono- and bicyclic-piperidine and pyrrolidine derivatives is presented, employing a highly selective cross metathesis (CM) reaction followed by a domino reduction–cyclization process.